Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription

Articles published in
Oncol Rep
    March 2018
  1. LIU X, Kong C, Zhang Z
    miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
    Oncol Rep. 2018 Mar 6. doi: 10.3892/or.2018.6300.
    >> Share

  2. LIU S, Jiang H, Wen H, Ding Q, et al
    Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
    Oncol Rep. 2018 Mar 5. doi: 10.3892/or.2018.6294.
    >> Share

    January 2018
  3. MA J, Ge J, Xue X, Xiu W, et al
    Targeting bladder cancer using activated T cells armed with bispecific antibodies.
    Oncol Rep. 2018 Jan 11. doi: 10.3892/or.2018.6211.
    >> Share

    December 2017
  4. TAKAMURA T, Horinaka M, Yasuda S, Toriyama S, et al
    FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.
    Oncol Rep. 2017 Dec 1. doi: 10.3892/or.2017.6127.
    >> Share

    September 2017
  5. ZHAO X, Ji Z, Xie Y, Liu G, et al
    MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5992.
    >> Share

  6. KOU B, Liu W, Xu X, Yang Y, et al
    Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5988.
    >> Share

  7. HUANG B, Zhang J, Zhang X, Huang C, et al
    Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5959.
    >> Share

    August 2017
  8. TSUJITA Y, Horiguchi A, Tasaki S, Isono M, et al
    STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Oncol Rep. 2017 Aug 11. doi: 10.3892/or.2017.5902.
    >> Share

  9. GAO SL, Kong CZ, Zhang Z, Li ZL, et al
    TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5883.
    >> Share

    July 2017
  10. WANG SC, Wang ST, Liu HT, Wang XY, et al
    Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1survivin downregulation at the late phase of treatment.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5795.
    >> Share

    June 2017
  11. WANG S, Liu B, Zhang J, Sun W, et al
    Centromere protein U is a potential target for gene therapy of human bladder cancer.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5769.
    >> Share

  12. WANG H, Zhong J, Wu C, Liu Y, et al
    Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells.
    Oncol Rep. 2017 Jun 12. doi: 10.3892/or.2017.5711.
    >> Share

  13. RADY M, Mostageer M, Rohde J, Zaghloul A, et al
    Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
    Oncol Rep. 2017 Jun 2. doi: 10.3892/or.2017.5695.
    >> Share

    May 2017
  14. BA M, Cui S, Wang B, Long H, et al
    Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Oncol Rep. 2017;37:2761-2770.
    >> Share

    April 2017
  15. YUAN SY, Shiau MY, Ou YC, Huang YC, et al
    Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5608.
    >> Share

  16. WU D, Niu X, Tao J, Li P, et al
    MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5607.
    >> Share

    March 2017
  17. LI W, Liu J, Zou D, Cai X, et al
    Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Oncol Rep. 2017;37:1461-1468.
    >> Share

    January 2017
  18. CHEN JF, Yu BX, Yu R, Ma L, et al
    Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.
    Oncol Rep. 2017 Jan 5. doi: 10.3892/or.2017.5356.
    >> Share

    December 2016
  19. YU G, Jia Z, Dou Z
    miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5326.
    >> Share

    October 2016
  20. COCCIA A, Mosca L, Puca R, Mangino G, et al
    Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5150.
    >> Share

  21. HORI S, Miyake M, Onishi S, Tatsumi Y, et al
    Clinical significance of alpha and betaKlotho in urothelial carcinoma of the bladder.
    Oncol Rep. 2016;36:2117-25.
    >> Share

    September 2016
  22. KOBAYASHI K, Matsumoto H, Matsuyama H, Fujii N, et al
    Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
    Oncol Rep. 2016 Sep 1. doi: 10.3892/or.2016.5061.
    >> Share

  23. ZHANG Y, Zhang Z, Li Z, Gong D, et al
    MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
    Oncol Rep. 2016;36:1293-300.
    >> Share

    August 2016
  24. SHIN SS, Park SS, Hwang B, Moon B, et al
    MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5052.
    >> Share

  25. WANG J, Zhao X, Shi J, Pan Y, et al
    miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5040.
    >> Share

  26. SHIN SS, Park SS, Hwang B, Kim WT, et al
    MicroRNA-106a suppresses proliferation, migration, and invasion of bladder cancer cells by modulating MAPK signaling, cell cycle regulators, and Ets-1-mediated MMP-2 expression.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5015.
    >> Share

  27. ZHANG N, Bi X, Zeng Y, Zhu Y, et al
    TGF-beta1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
    Oncol Rep. 2016;36:977-83.
    >> Share

    July 2016
  28. HUANG J, Wang B, Hui K, Zeng J, et al
    miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4940.
    >> Share

  29. YIN X, Xu C, Zheng X, Yuan H, et al
    SnoN suppresses TGF-beta-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1gamma-dependent manner.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4939.
    >> Share

  30. YANG X, Zhang F, Luo J, Pang J, et al
    A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
    Oncol Rep. 2016;36:79-89.
    >> Share

    June 2016
  31. CHUNG YH, Kim D
    RIP kinase-mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin-treated bladder cancer cells.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4895.
    >> Share

  32. HU KY, Wang G, Liu PF, Cao YW, et al
    Targeting of MCT1 and PFKFB3 influences cell proliferation and apoptosis in bladder cancer by altering the tumor microenvironment.
    Oncol Rep. 2016 Jun 16. doi: 10.3892/or.2016.4884.
    >> Share

    May 2016
  33. CHEN F, Chen X, Yang D, Che X, et al
    Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4794.
    >> Share

  34. DENG QF, Sun X, Liang ZF, Zhang ZQ, et al
    Cigarette smoke extract induces the proliferation of normal human urothelial cells through the NF-kappaB pathway.
    Oncol Rep. 2016;35:2665-72.
    >> Share

    December 2015
  35. KANG M, Ho JN, Kook HR, Lee S, et al
    Theracurmin(R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4537.
    >> Share

  36. SUN Y, Guan Z, Liang L, Cheng Y, et al
    HIF-1alpha/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4536.
    >> Share

  37. WANG X, Chen E, Yang X, Wang Y, et al
    5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4492.
    >> Share

    November 2015
  38. YOON HY, Kim YJ, Kim JS, Kim YW, et al
    RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
    Oncol Rep. 2015 Nov 11. doi: 10.3892/or.2015.4409.
    >> Share

    October 2015
  39. PAN XW, Li L, Huang Y, Huang H, et al
    Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.
    Oncol Rep. 2015 Oct 16. doi: 10.3892/or.2015.4335.
    >> Share

    September 2015
  40. GAO D, Hu H, Wang Y, Yu W, et al
    CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
    Oncol Rep. 2015 Sep 24. doi: 10.3892/or.2015.4310.
    >> Share

    August 2015
  41. TAKEUCHI H, Mmeje CO, Jinesh GG, Taoka R, et al
    Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
    Oncol Rep. 2015 Aug 21. doi: 10.3892/or.2015.4220.
    >> Share

    July 2015
  42. PARK SL, Cho TM, Won SY, Song JH, et al
    MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4119.
    >> Share

  43. LOMBARD AP, Lim RM, Nakagawa RM, Vidallo KD, et al
    Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4117.
    >> Share

    June 2015
  44. HUANG Y, Zhang SD, McCrudden C, Chan KW, et al
    The prognostic significance of PD-L1 in bladder cancer.
    Oncol Rep. 2015;33:3075-84.
    >> Share

    May 2015
  45. SUN E, Fan X, Wang L, Lei M, et al
    Recombinant hIFN-alpha2b-BCG inhibits tumor growth in a mouse model of bladder cancer.
    Oncol Rep. 2015 May 18. doi: 10.3892/or.2015.3985.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016